Capricor Therapeutics | CAPR - Le Bénéfice D'Exploitation





Le Bénéfice D'Exploitation Changement Date
Alterity Therapeutics Limited AUD -8.07M 302.4K 2025-12
Bioline Rx USD -2.21M 96K 2025-09
Capricor Therapeutics USD -29.16M 2.87M 2025-12
Cipla INR 6.14B 3.63B 2026-03
Cytokinetics USD -181.23M 2.86M 2026-03
Geron USD -236K 10.55M 2026-03
Grifols EUR 320.55M 91.01M 2025-12
Immunic USD -23.33M 2.67M 2025-12
J&J USD 6.62B 1.03B 2026-03
Plus Therapeutics USD -5.74M 1.26M 2025-12
Prothena USD -27.21M 12.55M 2025-12
PTC Therapeutics USD 45.89M 127.51M 2026-03
Sarepta Therapeutics USD 358.43M 768.52M 2026-03